Bradykinin formation during processing for cellular labelling may cause side-effects

Eur J Nucl Med. 1996 Jul;23(7):857-8. doi: 10.1007/BF00843716.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology
  • Bradykinin / adverse effects*
  • Bradykinin / metabolism*
  • Dextran Sulfate / adverse effects*
  • Female
  • Humans
  • Isotope Labeling
  • Leukocytes*
  • Male
  • Middle Aged

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Dextran Sulfate
  • Bradykinin